Molecular Assemblies announced that it has closed an oversubscribed $24 million Series A financing with significant investment from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, and Argonautic Ventures. In addition LYFE Capital has joined the syndicate.

Molecular Assemblies is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products.